Trends & Forecasts

New techniques in solid state chemistry are transforming the pharmaceutical landscape in drug formulation and delivery.

How AI-driven process optimization could lower costs and improve success rates in drug development.

Claus Zieler from Astellas and EFPIA addresses the challenges facing innovation in Europe, including regulatory burdens and access to medicines.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

How will the biopharma industry evolve over the next 10 years? We speak with experts from Sartorius and the USP.

PicnicHealth Co-founder and CEO Noga Leviner foresees AI as the augur of greater observational research

Alfred Marchler and Peter Hirst discuss the biggest disruptors shaping the next decade.

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.

Technological advances are opening up new drug development opportunities for rare diseases.